Nonwalking response to fampridine in patients with multiple sclerosis in a real-world setting

OBJECTIVES: Mobility impairments constitute a long-term burden in patients with multiple sclerosis (MS). Currently there is evidence that the drug fampridine may improve nonwalking symptoms in MS patients. The main objective of this study is to analyze whether participants showing a beneficial walki...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Ther Adv Chronic Dis
Главные авторы: Rodriguez-Leal, Francisco Alejandro, Haase, Rocco, Akgün, Katja, Eisele, Judith, Proschmann, Undine, Schultheiss, Thorsten, Kern, Raimar, Ziemssen, Tjalf
Формат: Artigo
Язык:Inglês
Опубликовано: SAGE Publications 2019
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6475844/
https://ncbi.nlm.nih.gov/pubmed/31037211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622319835136
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы